Search

for
Search:

Did you mean LHRH?

GlossaryGonadotropin-releasing hormone (LHRH)

regulates release of reproductive hormones from the pituitary gland

Gonadotropin-releasing hormone (GnRH) is a key hormone produced in the hypothalamus of the brain. It regulates the release of two other important hormones from the pituitary gland: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are crucial for reproductive function, including the development of eggs in ovaries and sperm in testes.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 155 results

research Alopecia in a Premenopausal Breast Cancer Woman Treated with Letrozole and Triptorelin

15 citations , October 2003 in “Annals of Oncology”

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

research Estrogen Deprivation Effects of Endocrine Therapy in Breast Cancer Patients: Incidence, Management and Outcome

7 citations , September 2023 in “Cancer Treatment Reviews”

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

research Laser Hair Removal for Genital Gender Affirming Surgery

33 citations , May 2016 in “Translational andrology and urology”

Laser hair removal before genital surgery can prevent complications and improve patient satisfaction.

Evaluating Changes in the Breast Cancer-Related Quality of Life of Young Women with Breast Cancer: Long-Term Results from a Multicenter Prospective Cohort

research Evaluating Changes in the Breast Cancer-Related Quality of Life of Young Women with Breast Cancer: Long-Term Results from a Multicenter Prospective Cohort

May 2025 in “Therapeutic Advances in Medical Oncology”

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

research Study Answers Some Questions About Androgen Suppression Pre-Radiation, But Not All

March 2015 in “Oncology Times”

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

View more "lhrha" in research →

Community Join

1 / 1 results

community Why haven’t we seen anything about this

in Research/Science 17 upvotes 5 years ago

A double blind, placebo-controlled study that looked into the potential effectiveness of topical fluridil for treating male androgenetic alopecia, showing increased anagen to telogen ratios with no reported side effects on libido or sexual performance.